|
PAIP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.723570E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.129800E-02 |
| Normal-vs-Stage2 |
9.488800E-01 |
| Normal-vs-Stage3 |
7.204000E-01 |
| Normal-vs-Stage4 |
3.684400E-01 |
| Stage1-vs-Stage2 |
3.323200E-01 |
| Stage1-vs-Stage3 |
4.908800E-01 |
| Stage1-vs-Stage4 |
9.401200E-01 |
| Stage2-vs-Stage3 |
7.520400E-01 |
| Stage2-vs-Stage4 |
5.451600E-01 |
| Stage3-vs-Stage4 |
7.204000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.027800E-01 |
| Normal-vs-AfricanAmerican |
2.161400E-01 |
| Normal-vs-Asian |
5.976000E-01 |
| Caucasian-vs-AfricanAmerican |
8.252400E-01 |
| Caucasian-vs-Asian |
8.524400E-01 |
| AfricanAmerican-vs-Asian |
9.030400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.658140E-02 |
| Normal-vs-Female |
2.169200E-01 |
| Male-vs-Female |
1.220280E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.852000E-01 |
| Normal-vs-Extreme_Weight |
5.529900E-02 |
| Normal-vs-Obese |
6.483400E-01 |
| Normal-vs-Extreme_Obese |
1.414440E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.145200E-01 |
| Normal_Weight-vs-Obese |
6.468200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.191200E-01 |
| Extreme_Weight-vs-Obese |
1.979200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.268600E-01 |
| Obese-vs-Extreme_Obese |
2.420200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.976600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.768800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.335760E-02 |
| Normal-vs-Age(81-100Yrs) |
2.918200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.001000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.786650E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.170400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.159840E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.746400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.928000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.125160E-01 |
| Normal-VS-Type2 PRCC |
5.195000E-01 |
| Normal-VS-KIRP CIMP |
1.428030E-02 |
| Normal-VS-Unclassified PRCC |
6.495000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.817800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.983400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.791400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.818770E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.815600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.226600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.823950E-02 |
| Normal-vs-N1 |
6.779400E-01 |
| Normal-vs-N2 |
2.888400E-02 |
| N0-vs-N1 |
4.200500E-02 |
| N0-vs-N2 |
4.468200E-01 |
| N1-vs-N2 |
1.539030E-01 |
|
|
